Optum Rx — D&A
UnitedHealth Group Optum Rx — D&A decreased by 16.8% to $173M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.0%, from $211M to $173M. Over 4 years (FY 2021 to FY 2025), Optum Rx — D&A shows an upward trend with a 9.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate significant recent capital investments or the amortization of newly acquired intangible assets, while a decrease could suggest aging infrastructure or a reduction in acquisition-related intangible write-offs.
Detailed definition
This metric represents the non-cash expense allocated to the Optum Rx pharmacy care services segment for the wear and te...
Peer comparison
Comparable to depreciation and amortization expenses reported by other pharmacy benefit managers and healthcare services providers, though it is highly dependent on the company's specific M&A history and capital investment cycle.
unh_segment_optum_rx_depreciation_and_amortizationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.25M | $149.25M | $149.25M | $160.75M | $160.75M | $160.75M | $160.75M | $174M | $174M | $174M | $174M | $180M | $206M | $209M | $198M | $211M | $216M | $210M | $208M | $173M |
| QoQ Change | — | +0.0% | +0.0% | +7.7% | +0.0% | +0.0% | +0.0% | +8.2% | +0.0% | +0.0% | +0.0% | +3.4% | +14.4% | +1.5% | -5.3% | +6.6% | +2.4% | -2.8% | -1.0% | -16.8% |
| YoY Change | — | — | — | — | +7.7% | +7.7% | +7.7% | +8.2% | +8.2% | +8.2% | +8.2% | +3.4% | +18.4% | +20.1% | +13.8% | +17.2% | +4.9% | +0.5% | +5.1% | -18.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's optum rx — d&a?
- UnitedHealth Group (UNH) reported optum rx — d&a of $173M in Q1 2026.
- How has UnitedHealth Group's optum rx — d&a changed year-over-year?
- UnitedHealth Group's optum rx — d&a decreased by 18.0% year-over-year, from $211M to $173M.
- What is the long-term trend for UnitedHealth Group's optum rx — d&a?
- Over 4 years (2021 to 2025), UnitedHealth Group's optum rx — d&a has grown at a 9.1% compound annual growth rate (CAGR), from $597M to $845M.
- What does optum rx — d&a mean?
- The non-cash cost of using up physical equipment and intangible assets within the pharmacy care services business.